Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gate Control Theory of Pain, originally proposed by Melzack and Wall in 1965, describes a physiological mechanism located in the dorsal horn of the spinal cord that modulates the perception of pain (StatPearls, PMID: 31082115). According to this model, a 'gate' exists in the substantia gelatinosa where non-painful sensory input, carried by large-diameter A-beta nerve fibers, activates inhibitory interneurons. These interneurons subsequently inhibit the transmission of pain signals from small-diameter nociceptive fibers (A-delta and C fibers) to the brain, effectively 'closing' the gate to pain (NIH, 2023). This mechanism explains why physical stimuli, such as rubbing an injury, can alleviate the sensation of pain by providing competing non-nociceptive input. While the theory is a functional concept rather than a single molecular target, it is the foundation for numerous clinical interventions, including Transcutaneous Electrical Nerve Stimulation (TENS), spinal cord stimulation (SCS), and various pharmacological strategies aimed at enhancing inhibitory signaling. Modern interpretations of the theory also incorporate descending inhibitory pathways from the periaqueductal gray and medulla that further modulate the spinal gate (PubMed, PMID: 24535357).
Activation of inhibitory interneurons in the substantia gelatinosa of the spinal cord dorsal horn to suppress the transmission of nociceptive signals from primary afferent neurons to secondary transmission cells.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gate control theory of pain (GCT).